Patent ID: 8921050

Claim:
A method of diagnosing and treating renal cell carcinoma (RCC) in a mammalian subject comprising: (1) obtaining a sample of blood or tissue comprising a cell population from the subject; (2) detecting the presence or absence of a human endogenous retrovirus type E (HERV-E) antigen or of genetic material encoding a HERV-E antigen on or in RCC cells present in the cell population, wherein the HERV-E antigen is encoded by a nucleic acid sequence selected from the group consisting of: SEQ ID NO:11, SEQ ID NO:12, SEQ ID NO:45, and SEQ ID NO:47, wherein the presence of said HERV-E antigen or genetic material encoding HERV-E antigen on or in cells of the cell population is indicative of RCC in said mammalian subject; and (3) treating a subject determined to have said HERV-E antigen or genetic material encoding said HERV-E antigen on or in cells of the cell population for RCC, comprising administering to said subject a composition comprising an enriched allogeneic CD8+ T cell population reactive to a HERV-E antigen of SEQ ID NO:1.